Haiying Cheng Selected Research

Haiying Cheng Research Topics

Disease

32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2010
28	Lung Neoplasms (Lung Cancer) 12/2023 - 02/2013
23	Neoplasms (Cancer) 12/2023 - 03/2012
6	Hypoglycemia (Reactive Hypoglycemia) 12/2008 - 06/2006
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
3	Disease Progression 11/2023 - 01/2017
3	Adenocarcinoma of Lung 01/2018 - 03/2015
2	Inflammation (Inflammations) 01/2023 - 02/2018
2	Adenocarcinoma 01/2018 - 02/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2012 - 07/2011
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2008 - 06/2006
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Infantile Spasms (West Syndrome) 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Female Infertility 01/2023
1	Infertility (Sterility) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Meningitis 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Thyrotoxicosis 03/2021
1	Gastritis 02/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Vitiligo 10/2017
1	Melanoma (Melanoma, Malignant) 10/2017
1	Halo Nevus 10/2017
1	Epilepsy (Aura) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2006
6	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 04/2013
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2013
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2008
5	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
4	osimertinibIBA 01/2024 - 01/2018
4	durvalumabIBA 01/2024 - 03/2021
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2014
4	Epinephrine (Adrenaline)FDA LinkGeneric 12/2008 - 09/2007
3	PlatinumIBA 01/2022 - 04/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2013
3	AntibodiesIBA 01/2020 - 04/2012
3	AMP-Activated Protein KinasesIBA 10/2013 - 06/2006
3	Hypoglycemic Agents (Hypoglycemics)IBA 12/2008 - 09/2007
3	Retinaldehyde (Retinal)IBA 11/2008 - 04/2006
3	Glucagon (Glukagon)FDA Link 05/2008 - 09/2007
2	pembrolizumabIBA 11/2023 - 06/2020
2	CrizotinibIBA 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 05/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 01/2018
2	Cell-Free Nucleic AcidsIBA 01/2018 - 09/2017
2	Circulating Tumor DNAIBA 11/2017 - 09/2017
2	Complement System Proteins (Complement)IBA 09/2017 - 02/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 01/2017
2	UrocortinsIBA 10/2013 - 06/2006
2	Corticotropin-Releasing HormoneIBA 10/2013 - 09/2007
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 10/2013 - 09/2007
2	Gemcitabine FDA Link 03/2012 - 07/2011
2	Insulin (Novolin)FDA Link 12/2008 - 06/2006
1	Pyruvate Dehydrogenase (Lipoamide)IBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	fibroblast growth factor 13IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	EnzymesIBA 01/2023
1	B7-H1 AntigenIBA 09/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	thiazolyl blueIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	lorlatinibIBA 01/2022
1	AfatinibIBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	Albumin-Bound Paclitaxel FDA Link 01/2019
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 02/2018
1	Therapeutic UsesIBA 02/2018
1	brigatinibIBA 01/2018
1	Immune Checkpoint ProteinsIBA 01/2018
1	alectinibIBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 01/2018
1	atezolizumabIBA 10/2017
1	LigandsIBA 10/2017

Therapy/Procedure

25	Therapeutics 11/2023 - 06/2006
10	Immunotherapy 12/2023 - 02/2017
9	Drug Therapy (Chemotherapy) 01/2022 - 03/2012
4	Chemoradiotherapy 11/2023 - 03/2021
3	Radiotherapy 11/2023 - 01/2017
1	Radioimmunotherapy 11/2023
1	Combined Modality Therapy 01/2023
1	Wearable Electronic Devices 11/2019
1	Acupuncture Points (Acupuncture Point) 02/2018
1	Percutaneous Collagen Induction 02/2018
1	Investigational Therapies (Experimental Therapy) 04/2017
1	Drug Tapering 03/2016